Nasdaq Continued Listing Requirements. The Company is as of the date hereof in compliance with applicable Nasdaq continued listing requirements. As of the date hereof there are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on Nasdaq.
Appears in 2 contracts
Samples: License Agreement (Icagen Inc), Purchase Agreement (Icagen Inc)
Nasdaq Continued Listing Requirements. The Except as set forth in the SEC Documents, the Company is as of the date hereof in compliance with applicable Nasdaq continued listing requirements. As Except as set forth in the SEC Documents, as of the date hereof there are no proceedings pending or, to the Company’s knowledge, threatened against the Company relating to the continued listing of the Common Stock on Nasdaq.
Appears in 1 contract
Nasdaq Continued Listing Requirements. The Except as set forth on Schedule 4.20, (a) the Company is as of the date hereof in compliance with applicable Nasdaq continued listing requirements. As of the date hereof ; (b) there are no proceedings pending or, to the Company’s knowledgeKnowledge, threatened against the Company relating to the continued listing of the Common Stock on Nasdaq and (c) the Company has not received any notice of, nor to the Company’s Knowledge is there any basis for, the delisting of the Common Stock from Nasdaq.
Appears in 1 contract
